In vitro effects of citral on the human myometrium: Potential adjunct therapy to prevent preterm births.

Víctor Manuel Muñoz-PérezMario I OrtizAndrés Salas-CasaJessica Pérez-GuerreroNarmi Castillo-PachecoGuillermo Barragán-RamírezMario Hernándes-Alejandro

Published in: Birth defects research (2021)

These properties place citral as a potentially safe and effective adjuvant agent in preterm birth cases, an obstetric and gynecological problem that requires urgent attention.

Keyphrases

preterm birth
gestational age
low birth weight
endothelial cells
early stage
pregnant women
pluripotent stem cells
working memory
preterm infants